1 / 8

Contraceptives Market Development Strategy, Regional Forecast To 2027

The contraceptives market is expected to reach US$ 29,629.4 million in 2028 from US$ 20,825.0 million in 2020; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028.<br>

Robert105
Download Presentation

Contraceptives Market Development Strategy, Regional Forecast To 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ContraceptivesMarket Analysis, Regional Outlook, Business Landscape 2027 Published Date : May 2022 Email: sales@theinsightpartners.com

  2. Email:sales@theinsightpartners.com Report Studies • Contraceptives Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Condoms, Intrauterine Product (IUDs), Vaginal Rings, Implants, Patches, Diaphragms, Emergency Contraceptives, Sponges, Others), End User (Home Care, Hospitals and Clinics), Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospital Pharmacy)

  3. Email:sales@theinsightpartners.com Contraceptives Market Overview • The Contraceptives Marketis expected to reach US$ 29,629.4 million in 2028 from US$ 20,825.0 million in 2020; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028. • Based on product, the condoms segment held the largest share of the market in 2020; whereas, the intrauterine product (IUDs) segment is expected to grow at the fastest CAGR during the forecast period. IUDs are popular and one of the most effective forms of birth control globally. Factors driving the growth of the segment are increasing rate of unintended pregnancies and launch of innovative products. Bayer received the US Food and Drug Administration (FDA) approval for Kyleena (levonorgestrel-releasing intrauterine system) 19.5 mg, a progestin-containing intrauterine system, that prevents pregnancy for up to five years.

  4. Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • By Product (Condoms, Intrauterine Product (IUDs), Vaginal Rings, Implants, Patches, Diaphragms, Emergency Contraceptives, Sponges, Others) • Distribution Channel(Retail Pharmacy, Online Pharmacy, Hospital Pharmacy) • End-User (Home Care, Hospitals and Clinics) Download Sample

  5. Email:sales@theinsightpartners.com Contraceptives Market Value CAGR of 8.0% (2021 - 2028) Download Sample

  6. Email:sales@theinsightpartners.com Company Profiles • Bayer AG • Cooper Companies, Inc. • Merck & Co., Inc • HLL Lifecare Limited • Church & Dwight, Inc. • Pregna International Limited • Mayer Laboratories, Inc. • Medicines360 • Prosan International B.V. • Cupid Limited Download Sample

  7. Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).

  8. THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related